Andrew Campbell

Andrew Campbell is an accomplished medical professional with extensive experience in clinical sciences and development within the pharmaceutical industry. Since January 2013, Andrew has held the position of Vice President, Clinical Sciences at AbbVie, overseeing areas such as Clinical Pharmacology, Data and Statistical Sciences, Epidemiology, Pharmacovigilance, R&D Quality, and JAPAC Development. Previous roles at AbbVie include Vice President and Therapeutic Head for Specialty Development, Executive Medical Director, and Asset Strategy Leader focused on Infectious Diseases and Women's Health, as well as Senior Medical Director for HCV Development. Prior to AbbVie, Andrew served as Senior Medical Director for the HCV Global Project Team at Abbott Laboratories and worked at Mount Sinai Medical Center as an Assistant Professor of Pediatric Infectious Diseases. Andrew holds an MD degree from the University of Louisville School of Medicine, earned between 1993 and 1997.